Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Current Leases (2018 - 2025)

Historic Current Leases for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $3.1 million.

  • Neurogene's Current Leases rose 759.8% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 759.8%. This contributed to the annual value of $2.9 million for FY2024, which is 1508.4% up from last year.
  • According to the latest figures from Q3 2025, Neurogene's Current Leases is $3.1 million, which was up 759.8% from $3.1 million recorded in Q2 2025.
  • Neurogene's 5-year Current Leases high stood at $3.1 million for Q2 2025, and its period low was $1.4 million during Q1 2023.
  • For the 3-year period, Neurogene's Current Leases averaged around $2.5 million, with its median value being $2.8 million (2024).
  • As far as peak fluctuations go, Neurogene's Current Leases skyrocketed by 8658.28% in 2024, and later soared by 759.8% in 2025.
  • Over the past 3 years, Neurogene's Current Leases (Quarter) stood at $2.6 million in 2023, then grew by 15.08% to $2.9 million in 2024, then grew by 4.35% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $3.1 million for Q2 2025, and $3.0 million during Q1 2025.